ArticleBMC cancer2026
Comprehensive analysis of tissue-derived small extracellular vesicles transcriptomic and extensively targeted lipidomics from patients with high-grade serous ovarian cancer.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing the frontiers of ovarian cancer therapy: a comprehensive synthesis of emerging cell death paradigms.Oncology reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundTissue-derived small extracellular vesicles (Ti-sEVs) are critical components of the tumor microenvironment. Nonetheless, the biological functions and potential clinical significance of Ti-sEVs lncRNAs and mRNAs in ovarian cancer have not been studied.
methodsWe collected 5 high-grade serous ovarian cancer specimen, 5 benign ovarian tumors, and 5 normal ovarian tissue specimens. Ti-sEVs were isolated, and high-throughput sequencing of lncRNA and mRNA and lipid metabolites of the three groups were performed. RT-qPCR confirmed the expression of lncRNA RMRP derived from Ti-sEVs of ovarian cancer. The prognostic value and immune cell infiltration were further analyzed.
resultsThe lncRNAs and mRNAs profiles of Ti-sEVs in ovarian cancer patients exhibited distinct differences from those in healthy controls and benign patients. The functions of the differential lncRNAs and mRNAs were related to immune response and metabolic reprogramming. The expression of RMRP was further verified in vitro. Public database analysis found that RMRP levels were associated with the prognosis of patients with ovarian cancer. The study found that the expression of RMRP was positively correlated with neutrophils.
conclusionThese findings revealed the Ti-sEVs transcriptome and extensively targeted lipidome characteristics from ovarian cancer patients, and comprehensive analysis showed that RMRP has the potential to become a promising prognostic biomarker candidate.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.